NEOG stock news · Neogen Corporation
Get alerts for NEOG
Follow Neogen Corporation (NEOG) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for NEOGNeogen's stock is going up today after it shared big plans for growth by 2031.
Good for NEOGNeogen set long-range sales and profit goals, and its latest quarter beat expectations. Its higher 2027 forecast supports a positive reading, though the long-range goals remain plans.
Neogen is now concentrating on growing its profits.
Good for NEOGNeogen reported higher sales and adjusted profit than expected, then raised its yearly sales forecast. Some orders came early and costs remain a concern, but growth in both businesses points to continued progress.
12 health care companies are changing prices before the market opens on Wednesday.
NeutralNeogen's stock rose 14% to $13.66 per share, and its Q1 results came out the day before. The article gives no results or explanation, so it does not change the company's outlook.
Neogen shares what happened during its first-quarter earnings call for 2027.
Good for NEOGNeogen's core sales grew 8.1%, and it raised its sales and adjusted profit forecasts for fiscal 2027. This points to a brighter outlook, though customer order timing helped growth.
12 health care stocks changed a lot in prices after the market closed on Tuesday.
NeutralNeogen shares rose about 9% after hours, and its first-quarter results came out that day. The article gives no results details, so it does not change the company's outlook.
Companies will share their earnings on October 6, 2026.
NeutralNeogen is scheduled to report quarterly results, with estimates of $0.05 per share and $208 million in sales. No actual results are included, so this notice alone does not change its outlook.
Will the S&P 500 start the day higher or lower?
NeutralNeogen is listed among Tuesday’s upcoming reports, but the article gives no results or company forecast. The market-wide signals do not show a clear change for its business.
Neogen's stock is down on Tuesday after the FDA warned about serious contamination in its HYCOAT product.
Bad for NEOGThe FDA warned Neogen’s CEO after linking contaminated HYCOAT to horse deaths. The findings raise enforcement and trust risks for Neogen, making this bad news for the company.